These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 34170659)

  • 1. Preventive Effects of
    Huang H; Li K; Lee Y; Chen M
    J Agric Food Chem; 2021 Jul; 69(26):7353-7366. PubMed ID: 34170659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of CKD on Uremic Toxins and Gut Microbiota.
    Rysz J; Franczyk B; Ławiński J; Olszewski R; Ciałkowska-Rysz A; Gluba-Brzózka A
    Toxins (Basel); 2021 Mar; 13(4):. PubMed ID: 33807343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pathomechanism and treatment of gut microbiota dysbiosis in chronic kidney disease and interventional effects of Chinese herbal medicine].
    Han WB; Liu YL; Wan YG; Sun W; Tu Y; Yang JJ; Wu W; He WM; Yao J
    Zhongguo Zhong Yao Za Zhi; 2017 Jul; 42(13):2425-2432. PubMed ID: 28840678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered microbiome in chronic kidney disease: systemic effects of gut-derived uremic toxins.
    Lau WL; Savoj J; Nakata MB; Vaziri ND
    Clin Sci (Lond); 2018 Mar; 132(5):509-522. PubMed ID: 29523750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interplay among gut microbiota, hypertension and kidney diseases: The role of short-chain fatty acids.
    Felizardo RJF; Watanabe IKM; Dardi P; Rossoni LV; Câmara NOS
    Pharmacol Res; 2019 Mar; 141():366-377. PubMed ID: 30639376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From the gastrointestinal tract (GIT) to the kidneys: live bacterial cultures (probiotics) mediating reductions of uremic toxin levels via free radical signaling.
    Vitetta L; Linnane AW; Gobe GC
    Toxins (Basel); 2013 Nov; 5(11):2042-57. PubMed ID: 24212182
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Li H; Shi J; Zhao L; Guan J; Liu F; Huo G; Li B
    J Agric Food Chem; 2021 Jan; 69(1):183-197. PubMed ID: 33353302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emodin via colonic irrigation modulates gut microbiota and reduces uremic toxins in rats with chronic kidney disease.
    Zeng YQ; Dai Z; Lu F; Lu Z; Liu X; Chen C; Qu P; Li D; Hua Z; Qu Y; Zou C
    Oncotarget; 2016 Apr; 7(14):17468-78. PubMed ID: 27003359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the gastrointestinal tract and microbiota on uremic toxins and chronic kidney disease development.
    Briskey D; Tucker P; Johnson DW; Coombes JS
    Clin Exp Nephrol; 2017 Feb; 21(1):7-15. PubMed ID: 26965149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut-Derived Protein-Bound Uremic Toxins.
    Graboski AL; Redinbo MR
    Toxins (Basel); 2020 Sep; 12(9):. PubMed ID: 32932981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the Preventive and Therapeutic Mechanisms of Probiotics in Chronic Kidney Disease through the Gut-Kidney Axis.
    Huang HW; Chen MJ
    J Agric Food Chem; 2024 Apr; 72(15):8347-8364. PubMed ID: 38571475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Potential Benefits and Controversies of Probiotics Use in Patients at Different Stages of Chronic Kidney Disease.
    Tian N; Li L; Ng JK; Li PK
    Nutrients; 2022 Sep; 14(19):. PubMed ID: 36235699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations to the Gut Microbiota and Their Correlation With Inflammatory Factors in Chronic Kidney Disease.
    Li F; Wang M; Wang J; Li R; Zhang Y
    Front Cell Infect Microbiol; 2019; 9():206. PubMed ID: 31245306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating the Efficacy of Kidney-Protective
    Tsai CW; Huang HW; Lee YJ; Chen MJ
    Animals (Basel); 2024 Feb; 14(4):. PubMed ID: 38396596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synbiotics Alleviate the Gut Indole Load and Dysbiosis in Chronic Kidney Disease.
    Yang CY; Chen TW; Lu WL; Liang SS; Huang HD; Tseng CP; Tarng DC
    Cells; 2021 Jan; 10(1):. PubMed ID: 33435396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blueberry, cranberry, raspberry, and strawberry as modulators of the gut microbiota: target for treatment of gut dysbiosis in chronic kidney disease? From current evidence to future possibilities.
    Coutinho-Wolino KS; Melo MFS; Mota JC; Mafra D; Guimarães JT; Stockler-Pinto MB
    Nutr Rev; 2024 Jan; 82(2):248-261. PubMed ID: 37164634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiota and prebiotics modulation of uremic toxin generation.
    Koppe L; Fouque D
    Panminerva Med; 2017 Jun; 59(2):173-187. PubMed ID: 28001024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysbiosis-Related Advanced Glycation Endproducts and Trimethylamine N-Oxide in Chronic Kidney Disease.
    Taguchi K; Fukami K; Elias BC; Brooks CR
    Toxins (Basel); 2021 May; 13(5):. PubMed ID: 34069405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal microbiota alterations in chronic kidney disease and the influence of dietary components.
    Ondrussek-Sekac M; Navas-Carrillo D; Orenes-Piñero E
    Crit Rev Food Sci Nutr; 2021; 61(9):1490-1502. PubMed ID: 32393049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uremia-Induced Gut Barrier Defect in 5/6 Nephrectomized Mice Is Worsened by
    Tungsanga S; Panpetch W; Bhunyakarnjanarat T; Udompornpitak K; Katavetin P; Chancharoenthana W; Chatthanathon P; Somboonna N; Tungsanga K; Tumwasorn S; Leelahavanichkul A
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.